Generate a tailored SOP for Dr. Maya Thanou. Improve your application with a focused, well-structured draft.
Professor Thanou based in the Institute of Pharmaceutical Science at King’s College London specializes in Pharmaceutical Nanotechnology. She completed her PhD at the LACDR (Leiden/Amsterdam Centre for Drug Research) with a focus on therapeutic peptides for cancer treatment. In 2000, she was awarded the AAPS award for excellence in Graduate Research. After a brief tenure at Kytogenics Pharmaceuticals, she took an academic position at the School of Pharmacy, Cardiff University, where she lectured on Polymer Therapeutics and Drug Delivery. In 2004, she received the prestigious Dorothy Hodgkin Royal Society Research Fellowship, which allowed her to continue her research at Imperial College London in the Department of Chemistry, concentrating on cancer gene therapy. She joined King’s College in 2009, where her current role emphasizes postgraduate teaching and research in Pharmaceutical Nanotechnology. Her research endeavors include chemical design and development of theranostic nanoparticles, materials for microwave sensing and hyperthermia, and novel nanomaterials for bioimaging, supported by various funding bodies, including EPSRC, BBSRC MRC, and the King's Commercialisation Institute. She collaborates with numerous biotech and medical device firms as an industry trustee of the British Society for Nanomedicine and is a co-inventor on ten patents.
Requirements are consistent across King's Business School and Social Science & Public Policy departments for standard Master's entries.